Ultralife Corporation designs, manufactures, installs, and maintains power, and communication and electronic systems for government, defense, and commercial sectors worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium ion cells, multi-kilowatt module lithium ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
Read More…
Industry, Sector and Symbol
Industry Miscellaneous electrical machinery, equipment, & supplies
Sub-IndustryN/A
SectorComputer and Technology
Phone315-332-7100
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$87.19 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date11/7/2019 (Estimated)
OptionableOptionable
Ultralife (NASDAQ:ULBI) Frequently Asked Questions
What is Ultralife's stock symbol?
Ultralife trades on the NASDAQ under the ticker symbol "ULBI."
How will Ultralife's stock buyback program work?
Ultralife declared that its board has authorized a stock buyback plan on Thursday, November 1st 2018, which authorizes the company to buyback 2,500,000 outstanding shares, according to EventVestor. This buyback authorization authorizes the company to reacquire shares of its stock through open market purchases. Shares buyback plans are often an indication that the company's board believes its stock is undervalued.
How were Ultralife's earnings last quarter?
Ultralife Corp. (NASDAQ:ULBI) posted its quarterly earnings data on Thursday, August, 1st. The technology company reported $0.18 earnings per share for the quarter. The technology company earned $29.40 million during the quarter. Ultralife had a net margin of 26.62% and a return on equity of 24.48%. View Ultralife's Earnings History.
When is Ultralife's next earnings date?
Has Ultralife been receiving favorable news coverage?
News coverage about ULBI stock has been trending positive recently, InfoTrie Sentiment reports. The research group ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Ultralife earned a coverage optimism score of 2.5 on InfoTrie's scale. They also assigned news headlines about the technology company a news buzz of 6.0 out of 10, indicating that recent press coverage is somewhat likely to have an effect on the company's share price in the near term. View News Stories for Ultralife.
Are investors shorting Ultralife?
Ultralife saw a drop in short interest during the month of July. As of July 31st, there was short interest totalling 76,400 shares, a drop of 10.3% from the June 30th total of 85,200 shares. Based on an average daily trading volume, of 35,300 shares, the short-interest ratio is currently 2.2 days. Approximately 0.9% of the shares of the stock are sold short. View Ultralife's Current Options Chain.
Who are some of Ultralife's key competitors?
Some companies that are related to Ultralife include Highpower International (HPJ), Arotech (ARTX), Flux Power (FLUX), Sono-Tek (SOTK), CBAK Energy Technology (CBAT), Polar Power (POLA), CBAK Energy Technology (CBAK), Security Devices International (SDEV), FuelCell Energy (FCEL), Evans & Sutherland Computer (ESCC), Manhattan Scientifics (MHTX), Environmental Tectonics (ETCC), Oakridge Global Energy Solutions (OGES) and Wireless Xcessories Group (WIRX).
What other stocks do shareholders of Ultralife own?
Who are Ultralife's key executives?
Ultralife's management team includes the folowing people:
- Mr. Michael D. Popielec, CEO, Pres & Director (Age 57)
- Mr. Philip A. Fain, CFO, Treasurer & Corp. Sec. (Age 64)
Who are Ultralife's major shareholders?
Ultralife's stock is owned by many different of institutional and retail investors. Top institutional investors include THB Asset Management (4.07%), Vanguard Group Inc. (3.24%), Russell Investments Group Ltd. (2.70%), Renaissance Technologies LLC (2.14%), Essex Investment Management Co. LLC (1.22%) and BlackRock Inc. (1.07%). Company insiders that own Ultralife stock include Philip A Fain, Thomas Louis Saeli and W Shaw Robert. View Institutional Ownership Trends for Ultralife.
Which major investors are selling Ultralife stock?
Which major investors are buying Ultralife stock?
ULBI stock was purchased by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., BlackRock Inc., Teton Advisors Inc., Essex Investment Management Co. LLC, Renaissance Technologies LLC, Ancora Advisors LLC, Vanguard Group Inc. and THB Asset Management. Company insiders that have bought Ultralife stock in the last two years include Philip A Fain, Thomas Louis Saeli and W Shaw Robert. View Insider Buying and Selling for Ultralife.
How do I buy shares of Ultralife?
Shares of ULBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Ultralife's stock price today?
One share of ULBI stock can currently be purchased for approximately $8.57.
How big of a company is Ultralife?
What is Ultralife's official website?
How can I contact Ultralife?
Ultralife's mailing address is 2000 TECHNOLOGY PARKWAY, NEWARK NY, 14513. The technology company can be reached via phone at 315-332-7100.
MarketBeat Community Rating for Ultralife (NASDAQ ULBI)
MarketBeat's community ratings are surveys of what our community members think about Ultralife and other stocks. Vote "Outperform" if you believe ULBI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ULBI will underperform the S&P 500 over the long term. You may vote once every thirty days.
